Genetics of head and neck cancer: Advances in molecular research

Authors

DOI:

https://doi.org/10.33448/rsd-v11i10.32924

Keywords:

Tumor Biomarkers; Carcinogenesis; Epigenetics.

Abstract

Most cases of head and neck cancer (HNC) originate from squamous cells and include tumors that arise in the epithelium of the nasal and oral cavity, paranasal sinuses, pharynx and larynx. More than half a million cases are diagnosed each year. The treatment for this neoplasm is considered a challenge, due to its intratumoral heterogeneity and the various anatomical subsites. In addition to genetic factors, it is also necessary to consider environmental components and gene-environment interactions, which can induce susceptibility to the disease. The main focus of therapies is to decrease side effects as well as increase the overall survival of patients. Due to the great complexity in tumor heterogeneity, a better understanding of the epigenetic mechanisms is of paramount importance for the development of therapies for this neoplasm. Given this context, this work aims to carry out a literature review regarding the genetics of head and neck cancer, as well as advances in molecular research. A total of 74 articles were selected, which provide a comprehensive view on the development of research aimed at clinical applications in diagnosis, prevention and treatment, whose research source was PubMed. According to the literature, the elucidation of the epigenetic and genetic mechanisms associated with carcinogenesis have a relevant role in the progression and response to treatment, the understanding of their participation may provide insights into their relationship in tumorigenesis, which are essential for precision medicine, contributing to personalized and patient-directed therapies.

References

Ali, J., Sabiha, B., Jan, H.U., Haider, S.A., Khan, A.A., Ali, S.S. (2017). Genetic etiology of oral cancer. Oral Oncology, 70, 23-28.

Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., Sauter, T., Tavassoli, M. (2019). Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death & Disease, 10(8), 540.

Arantes, L.M.R.B., De Carvalho, A.C., Melendez, M.E., Lopes, C.A. (2018). Serum, plasma and saliva biomarkers for head and neck cancer. Expert Review of Molecular Diagnostics, 18(1), 85-112.

Azulay, E.E., Cooks, T., Elkabets, M. (2020). Potential oncogenic roles of mutant-p53-derived exosomes in the tumor–host interaction of head and neck cancers. Cancer Immunology, Immunotherapy, 69(2), 285-292.

Bakhtiar, S.M., Ali, A., Barh, D. (2015). Epigenetics in Head and Neck Cancer. Methods In Molecular Biology, 751-769.

Bashyam, M.D., Animireddy, S., Bala, P., Naz, A., George, S.A. (2019). The Yin and Yang of cancer genes. Gene, 704, 121-133.

Birkeland, A.C., Ludwig, M.L., Spector, M.E., Brenner, J.C. (2016). The potential for tumor suppressor gene therapy in head and neck cancer. Discover Medicine, 21(113), 41-47.

Bornstein, S., Schmidt, M., Choonoo, G., Levin, T., Gray, J., Thomas, C.R.J., Wong, M., M.W.S. (2016). IL-10 and integrin signaling pathways are associated with head and neck cancer progression. BMC Genomics, 17(1), 17-38.

Brennan, M.T., Treister, N.S., Sollecito, T.P., Schmidt, B.L., Patton, L.L., Yang, Y., Lin, A., Elting, L.S., Hodges, J.S., Lalla, R.V. (2020). Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy. Head & Neck, 43(1), 164-172.

Brown, Geoffrey. (2021). Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells. International Journal Of Molecular Sciences, 22(18), 9667.

Burian, M; Neuchrist, Cs. (2021). Status quo der Immunonkologie bei Plattenepithelkarzinomen des Kopf-Halsbereichs. Wiener Medizinische Wochenschrift, 172(1-2), 31-34.

Chen, L., Zhang, Y.H., Lu, G., Huang, T., Cai, Y.D. (2017). Analysis of cancer-related lncRNAs using gene ontology and KEGG pathways. Artificial Intelligence In Medicine, 76, 27-36.

Chen, T.H., Chang, P.M., Yang, M.H. (2019). Novel immune-modulating drugs for advanced head and neck cancer. Head Neck, 41, 46-56.

Chen, Z.F., Wang, Y., Sun, L.L., Ding, S.Y., Jinag, H. (2020). LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis. European Review For Medical And Pharmacological Sciences, 24(10), 5436-5445.

Colevas, A.D., Yom, S.S., Pfister, D.G., Spencer, S., Adelstein, D., Adkins, D., Brizel, D.M., Burtness, B., Busse, P.M., Caudell, J.J., Cmelak, A.J., Eisele, D.W., Fenton, M., Foote, R.L., Gilbert, J., Gillison, M.L., Haddad, R.I., Hicks, W.L., Hitchcock, Y.J., Jimeno, A., Leizman, D., Maghami, E., Mell, L.K., Mittal, B.B., Pinto, H.A., Ridge, J.A., Rocco, J., Rodriguez, C.P., Shah, J.P., Weber, R.S., Witek, M., Worden, F., Zhen, W., Burns, J.L., Darlow, S.D. (2018). NCCN Guidelines Insights: head and neck cancers, version 1.2018. Journal Of The National Comprehensive Cancer Network, 16(5), 479-490.

Deloch, L., Derer, A., Hartmann, J., Frey, B., Fietkau, R., Gaipl, U.S. (2016). Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation. Frontiers In Oncology, 6, 1-16.

Dias, Correia, J. H. R., & Dias, C, A. A. (2007). Funcionalidades do RNA não codificantes (ncRNA) e pequenos RNA reguladores, nos mamíferos. Revista Electrónica de Veterinária, 3(10), 1-22.

Dsouza, V.L., Adiga, D., Sriharikrishnaa, S., Suresh, P.S., Chatterjee, A., Kabekkodu, S.P. (2021). Small nucleolar RNA and its potential role in breast cancer – A comprehensive review. Biochimica et Biophysica Acta (BBA), 1885(1), 188501.

Esteller, M. (2011). Non-coding RNAs in human disease. Nature Reviews Genetics, 12(12) 861-874.

Farmer, Z.L., Kim E.S., Carrizosa, D.R. (2019). Gene Therapy in Head and Neck Cancer. Oral And Maxillofacial Surgery Clinics Of North America, 31(1) 117-124, 2019.

Feng, M., Duan, R., Gao, Y., Zhang, H., Qiao, Y., Li Q., Zhao, F. (2021). Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Intraepithelial Neoplasia in Chinese Women Living With HIV. Frontiers in Cellular and Infection Microbiology,11, 1-10.

Firmino, N., Martinez, V.D., Rowbotham, D.A., Enfield, K.S.S., Bennewith, K.L., Lam, W.L. (2016). HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer. Oral Oncology, 55, 43-48.

García, C.D., Cai, Y., Qiu, W., Saeki, K., Friedman, R.A., Lee A., Li Y., Goldberg E.M., Stratikopoulos E.E., Parsons R., Lu C., Efstratiadis A., Philipone E.M., Yoon A.J., Su G.H. (2020). PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. Molecular Cancer Research, 8(6), 822-834.

Gao W., Zhang Y., Luo H., N.M., Zheng X., Hu W., Cui J., Xue X., Bo Y., Dai F., Lu Y., Yang D., Guo Y., Guo H., Li H., Zhang Y., Yang T., Li L., Zhang L., Hou R., Wen S., A.C., Ma T, Jin L, Xu W, Wu Y. (2020). Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1–AKT axis-mediated glycolysis. Cell Death & Disease, 11(10), 1-19.

Garofalo, M., Leva, G.D., Croce, C.M. (2014). MicroRNAs as anti-cancer therapy. Current Pharmaceutical Design, 20(33), 5328-5335.

Gillison, M.L., Chaturvedi, A.K., Anderson, W.F., Fakhry, C. (2015). Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. Journal of Clinical Oncology, 33(29), 3235-3242.

Gleich, L.L., Salamone, F.N. (2002). Molecular Genetics of Head and Neck Cancer. Cancer Control, 9(5), 369-378.

González, M.I.M., Torres, D.R.S, Vázquez, O.C. (2020). Seguimiento del cáncer de cabeza y cuello tratado. Lo que el radiólogo debe conocer. Radiología, 62(1), 13-27.

Guo, B., Li, D., Du, L., Zhu, X. (2020). piRNAs: biogenesis and their potential roles in cancer. Cancer Metastasis Ver, 39(2), 567-575.

Guo, W., Song, H. (2018). Development of Gene Therapeutics for Head and Neck Cancer in China: from bench to bedside. Human Gene Therapy, 29(2), 180-187.

Hanahan, Douglas. (2022) Hallmarks of Cancer: new dimensions. Cancer Discovery, 12(1), 31-46.

Instituto Nacional do Câncer. (2021). INCA promove campanha de prevenção ao câncer de cabeça e pescoço.

Jou, a., Hess, J. (2017). Epidemiology and Molecular Biology of Head and Neck Cancer. Oncol Res Treat, 40(6), 328-332.

Kanwal, R. (2015). Cancer epigenetics: an introduction. Methods in Molecular Biology, 1238, 3-25.

Karbalaie, N.M.H. et al. (2020). neck squamous cell carcinoma. European Journal of Cancer Prevention, 29(6), 523-530.

Kfouri, S.A., Eluf, N.J., Koifman, S., Curado, M.P., Menezes, A., Daudt, A.W., Wünsch, F.V. (2018). Fração de câncer de cabeça e pescoço atribuível ao tabaco e ao álcool em cidades de três regiões brasileiras. Revista Brasileira de Epidemiologia, 21, 1-12.

Liu, C.J., Shen, W.G., Peng, S.Y., Cheng, H.W., Kao, S.Y., Lin, S.C., Chang, K.W. (2014). MiR-134induces oncogenicity and metastasis in head and neck carcinoma through targetingWWOXgene. International Journal Of Cancer, 134(4), 811-821.

Lubek, J.E. (2018). Head and Neck Cancer Research and Support Foundations. Oral And Maxillofacial Surgery Clinics Of North America, 30(4), 459-469.

Marur, S., Forastiere, A.A. (2016). Head and Neck Squamous Cell Carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clinic Proceedings, 91(3), 386-396.

Marziliano, A., Teckie, S., Diefenbach, M.A. (2020). Alcohol-related head and neck cancer: Summary of the literature. Head Neck, 42(4), 732-738.

Matarredona, Q.S., Martínez, R.A.P, Serrano, B.E., Ortega, B.N., D.G.J. (2022). Factors associated with diagnosis delay in head and neck cancer. Acta Otorrinolaringologica, 73(1) 19-26.

McMahon, M., Contreras, A., Holm, M., Uechi, T., Forester C.M, Pang X., Jackson C., Calvert ME., Chen B., Quigley D.A., Luk J.M., Kelley R.K., Gordan J.D., Gill R.M., Blanchard S.C., Ruggero D. (2019). A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. Elife, 8, e48847.

Mendes, K. D. S., Silveira, R. C. C. P., &Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto -Enfermagem, 17(4), 758-764.

Miranda, F., C.L., Dos S.L.M.C, Silva, S.R.D, Furtado, G.P., Moraes, M.O., Pessoa, C. (2019). Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics, 14(12), 1164-1176.

Miranda, G.M., Loveless, R., Kowalski, L.P., Teng, Y. (2020). Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression. Cells, 10(2), 389.

Mittal, A., Sharma, A. (2021). Current status of systemic therapy in head and neck cancer. Journal Of Chemotherapy, 34(1), 9-24.

Moses, C., Garcia, B.B., Harvey, A.R., Blancafort, P. (2018). Hallmarks of cancer: the crispr generation. European Journal Of Cancer, 93, 10-18.

Nebbioso, A., Tambaro F.P., Dell'Aversana C., Altucci L. (2018). Cancer epigenetics: Moving forward. PLoS Genet, 14(6), e1007362.

Nor, J.E., Gutkind J.S. (2018). Head and Neck Cancer in the New Era of Precision Medicine. Journal Of Dental Research, 97(6), 601-602.

Peltomaki, P. (2012). Mutations and epimutations in the origin of cancer. Experimental Cell Research, 318(4), 299-310.

Peng, S.Y., Tu, H.F., Yang, C.C., Wu, C.H., Liu, C.J., Chang, K.W., Lin, S.C. (2018). MiR-134targetsPDCD7to reduce E-cadherin expression and enhance oral cancer progression. International Journal Of Cancer, 143(11), 2892-2904.

Polverini, P.J., D'Silva, N.J., Lei, Y.L. (2018). Precision Therapy of Head and Neck Squamous Cell Carcinoma. Journal Of Dental Research, 97(6), 614-621.

Puram, S.V., Rocco, J.W. (2015). Molecular Aspects of Head and Neck Cancer Therapy. Hematology/Oncology Clinics Of North America, 29(6), 971-992.

Qi, Z., Barrett T., Parikh A.S., Tirosh I., Puram S.V. (2019). Single-cell sequencing and its applications in head and neck cancer. Oral Oncology, 99,104441.

Rahman, Q.B., Iocca, O., Kufta, K., Shanti, R.M. (2020). Global Burden of Head and Neck Cancer. Oral Maxillofac Surg Clin North Am, 32(3), 367-375.

Rettig, M., D’ Souza, G. (2015). Epidemiology of head and neck cancer. Surg Oncol Clin N Am, 24(3):379-396.

Riaz, N., Morris, L.G., Lee, W., Chan, T.A. (2014). Unraveling the molecular genetics of head and neck cancer through genome-wide approaches. Genes & Diseases, 1(1), 75-86.

Saliminejad, K., Khorram, K.H.R. Soleymani Fard S, Ghaffari SH. (2019). An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. Journal of Cellular Physiology, 234(5), 5451-5465.

Santuray, R.T., Johnson, D.E., Grandis, J.R. (2018). New Therapies in Head and Neck Cancer. Trends In Cancer, 4(5), 385-396.

Senga, S.S., Grose R.P. (2021). Hallmarks of cancer-the new testament. Open Biol, 11(1), 01-20.

Silva, F.A., Roussenq, SC., Tavares, M.G.S., Souza, C.P.F.D; Mozzini, C.B., Benetti, M., Dias, M. (2020). Perfil Epidemiológico dos Pacientes com Câncer de Cabeça e Pescoço em um Centro Oncológico no Sul do Brasil. Revista Brasileira de Cancerologia, 66(1), 1-8.

Sklan, A., Collingridge, D. (2017). Treating head and neck cancer: for better or for worse? Lancet Oncol, 18(5), 570-571.

Starek, A., Podolak, I. (2009). Rakotwórcze działanie dymu tytoniowego [Carcinogenic effect of tobacco smoke]. Rocz Panstw Zakl Hig, 60(4), 299-310.

Stepan, K.O., Li, M.M., Kang, S.Y., Puram, S.V., (2020). Molecular margins in head and neck cancer: Current techniques and future directions. Oral Oncology, 01-10.

Su, J.L., Chen, P.S., Johansson, G., Kuo, M.L. (2012). Function and Regulation of Let-7 Family microRNAs. Microrna e, 1(1), 34-39.

Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249.

Szyfter, K. (2021). Genetics and Molecular Biology of Head and Neck Cancer. Biomoléculas, 11(9), 1293.

Szychot, E., Brodkiewicz, A., Peregud-Pogorzelski, J. (2013). Will therapies that target tumour suppressor genes be useful in cancer treatment?, Advances in Clinical and Experimental Medicine, 22(6), 861-864.

Thariat, J., Vignot, S., Lapierre, A., Falk, A.T., Guigay, J., Van, Obberghen.E., Milano, G. (2015). Integrating genomics in head and neck cancer treatment: promises and pitfalls. Critical Reviews In Oncology/Hematology, 95(3), 397-406.

Thompson., Thompson. (2008). Genética y genómica del câncer. Genética en medicina, 457-480.

Thorenoor, N., Slaby, O. (2015). Small nucleolar RNAs functioning and potential roles in. Tumor Biology, 36(1), 41-53.

Topper, M.J., Vaz, M., Marrone, K.A., Brahmer, J.R., Baylin, S.B. (2020). The emerging role of epigenetic therapeutics in immuno-oncology. Nature Reviews Clinical Oncology, 17(2), 75-90.

Tsao, S.W., Tsang, C.M., Lo, K.W. (2017). Epstein-Barr virus infection and nasopharyngeal carcinoma. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1732), 20160270.

Tumban, E. (2019). A Current Update on Human Papillomavirus-Associated Head and Neck Cancers. Viruses, 11(10), 922.

Villanueva, L., Álvarez-Errico, D., Esteller, M. (2020). The Contribution of Epigenetics to Cancer Immunotherapy. Trends In Immunology, 41(8), 676-691.

Vučičević, B.V., Fučić, A., Baranović, S., Blivajs, I., Milenović, M., Bišof, V., Rakušić, Z., Ceppi, M., Bruzzone, M. (2019). Environmental and behavioural head and neck cancer risk factors. Central European Journal Of Public Health, 27(2), 106-109.

Xing, L., Zhang, X., Zhang, X., Tong, D. (2020). Expression scoring of a small‐nucleolar‐RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer. Journal Of Cellular Physiology, 235(11), 8071-8084.

Wang, J., Zhang, X., Chen, W., Hu, X., Li, J., Liu, C. (2019). Regulatory roles of long noncoding RNAs implicated in cancer hallmarks. International Journal Of Cancer, 146(4), 906-916.

Winck, D.R.; &Brüggemann, O.M. Responsabilidade legal do enfermeiro em obstetrícia. Revista Brasileira de Enfermagem, 63(3), 464-469, 2010.

Zaimy, M.A., Saffarzadeh, N., Mohammadi, A., Pourghadamyari, H., Izadi, P., Sarli, A., Moghaddam, L.K., Paschepari, S.R., Azizi, H., Torkamandi, S., Tavakkoly-Bazzaz, J. (2017). New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Therapy, 24(6), 233-243.

Zhang, D. (2019). Targeting snoRNAs as an emerging method of therapeutic development for câncer. American Journal of Cancer Research, 9(8), 1504-1516.

Zhang, S., Ma, H., Zhang, D., Xie, S., Wang, W., Li, Q., Lin, Z., Wang, Y. (2018). LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death & Disease, 9(7), 1-16.

Zhang, W.W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M.J., Chandler, L.A., Lin, H., Hu, A., Xu, W., Lam, D.M. (2018). The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic. Human Gene Therapy, 29(2), 160-179.

Zou, A.E., Zheng, H., Saad, M.A., Rahimy, M., Ku, J., Kuo, S.Z., Honda, T.K., Wang-Rodriguez, J., Xuan, Y., Korrapati, A., Yu, V., Singh, P., Grandis, J.R., King, C.C., Lippman, S.M., Wang, X.Q., Hinton, A., Ongkeko, W.M. (2016). The non-coding landscape of head and neck squamous cell carcinoma. Oncotarget, 7(32), 51211-51222.

Zhou, L., Xu, N., Shibata, H., Saloura, V., Uppaluri, R (2021). Epigenetic modulation of immunotherapy and implications in head and neck cancer. Cancer And Metastasis Reviews, 40, 141-152.

Downloads

Published

05/08/2022

How to Cite

MATOS, A. G. de M. .; BARBOSA, E. da S.; MENDONÇA, A. F.; SOUSA, L. R. D.; SILVA, T. da C.; ARAÚJO, F. de B. S. .; ARAUJO, E. A.; SILVA, S. A. M.; DUARTE, W. E.; PINHO, J. D. Genetics of head and neck cancer: Advances in molecular research. Research, Society and Development, [S. l.], v. 11, n. 10, p. e391111032924, 2022. DOI: 10.33448/rsd-v11i10.32924. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/32924. Acesso em: 16 nov. 2024.

Issue

Vol. 11 No. 10

Section

Review Article

License

Copyright (c) 2022 Ana Gabrielly de Melo Matos; Eldevan da Silva Barbosa; Alania Frank Mendonça; Larissa Rodrigues De Sousa; Thaís da Conceição Silva; Francisca de Brito Souza Araújo; Eleilde Almeida Araujo; Sâmia Amélia Mendes Silva; Wesliany Everton Duarte; Jaqueline Diniz Pinho

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.